Aurora reports Q2 FY27 net revenue of $86.0 million
International medical cannabis net revenue reaches a record $61.4 million, up 44% year over year, with adjusted EBITDA of $14.0 million and $133.0 million in cash and no debt
See the latest news and media coverage for Aurora. We track all announcements, press releases, and industry mentions in real time, all in one place.
Cannabis brand offering medical and adult-use products
auroramj.comLast updated
In short: Aurora agreed to Organigram's acquisition offer and reported record international medical cannabis revenue.
International medical cannabis net revenue reaches a record $61.4 million, up 44% year over year, with adjusted EBITDA of $14.0 million and $133.0 million in cash and no debt
Organigram offers C$7.80 per Aurora share in cash, shares or a combination, and Aurora's board unanimously supports the transaction.
The call takes place at 8am EST, with further information available in the accompanying press release.
The board and special committee say the offer undervalues the company and urge investors to take no action.
Multiple companies have made offers for Aurora's business this year, but Tilray hasn't shown any...
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf"), a leading international provider of consumer and medical cannabis products...
Organigram CEO James Yamanaka says the transaction is a defining step in the company's strategy to build a disciplined, global cannabis leader.
EDMONTON, AB, Oct. 14, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NASDAQ: ACB), the Canadian-based leading global medical cannabis company...
Track Aurora and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Aurora and other trending companies.